March 1, 2008
By:
Jim Miller
The supply base for preclinical and clinical development services continues to expand in China.
|
December 1, 2007
By:
Eric S. Langer
China's pharma industry represents 5% of the world total. By 2010, China is expected to become the world's fifth largest pharmaceutical market.
|
November 1, 2007
By:
Eric S. Langer, Eliza Yibing Zhou
Biotechnology is definitely a hot topic in China—the country's administrators recently identified it as a "cornerstone of China's national economy by 2020." But most realize that getting there will require a better trained, specialized workforce than currently exists. The Chinese government has been pumping money into life sciences education as part of its plan to achieve a global biotechnological presence over the next 15 years.
|
August 21, 2007
The center of gravity for the pharmaceutical market is shifting to the Asia-Pacific region from the US and Europe, according to an analysis published by PricewaterhouseCoopers (New York, NY, www.pwc.com).
|
August 1, 2007
By:
Laura Bush
The corruption of China's food and drug sectors is not limited to one man. Likewise, real reform will require the efforts of many.
|
August 1, 2007
By:
Eric S. Langer
In 2006, China exported a total of $890 million in biologics to other countries—a 30.61% increase, compared with the previous year.
|
July 1, 2007
By:
Eric Langer, Eliza Yibing Zhou
Most Chinese biopharmaceuticals are relatively small and there are not enough of them to sustain a robust services sector.
|
June 1, 2007
By:
Eric S. Langer
In China, the presence of a substantial biogenerics industry reflects a growing need to provide healthcare to domestic populations, at a reasonable cost.
|
May 1, 2007
By:
Eric S. Langer
China's central government is aware of the need to improve intellectual property protection and enforcement.
|
|
